Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 10:41 PM
Ignite Modification Date: 2025-12-24 @ 10:41 PM
NCT ID: NCT02690935
Eligibility Criteria: Inclusion Criteria: * Age ≥18 years, male and female * Woman of childbearing age using effective contraceptive means * Patient having the faculties to understand and respect the constraints of the study * Symptomatic since at least two seasons and confirmed by positive skin test and/or the presence of IgE for grasses (prick test defined as positive if higher than or equal to half the negative control; IgE positive if at least class 3 (≥ 3.5 kU / L); these tests must have been performed at the latest at the first screening visit * Signature of the Informed Consent Form Exclusion Criteria: * Pregnant woman or woman wishing to become pregnant * Breastfeeding woman * Patient with an acute exacerbation of allergic rhinitis * Patient with uncontrolled asthma * Immunotherapy received within the last two years * Patient with a known lactose intolerance * Patient who participated in a clinical study in the previous three months * Patient who is not sufficiently motivated to engage on a follow-up period of 6 months or more, unable to complete the patient diary, or likely to travel or to move before the end of the study, * Patient taking nasal or bronchial inhaled corticosteroids on a long term basis (intermittent consumption during the season is permitted provided it is mentioned in the patient's records)
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT02690935
Study Brief:
Protocol Section: NCT02690935